nanostar.virginia.edu

Kester

Bio-  Mark Kester is a Professor of Pharmacology and the Co-Director of the NanoSTAR Institute of the University of Virginia. He was previously the G. Thomas Passananti Professor of Pharmacology at Penn State Hershey College of Medicine and the inaugural Director of the Penn State Center for NanoMedicine and Materials. Dr. Kester’s research interests include the design, characterization and validation of nanotechnologies for targeted drug delivery in cancer. His laboratory has evaluated nanoliposomes, nanodendrimers and nanocolloids as effective drug delivery vehicles for pharmacological and molecular agents. Recent work focuses on nontoxic nanoscale systemic delivery systems for hydrophobic pro-apoptotic lipids as well as siRNAs that target mutated tumorigenic proteins. Dr. Kester has consulted with, or founded, several companies that have the license to his nano”Solutions”. In addition, Dr.Kester is a co-author of Integrated Pharmacology, published by Elsevier, Ltd., which was recognized as a \\\"highly commended textbook\\\" by the British Medical Society.

 

First Name: 
Mark
Position: 
Professor of Pharmacology
Email: 
mk5vq@virginia.edu
Computing ID: 
mkv5q
Phone: 
(434) 243-2645
Photo: 
Classification: 
Related Researchers
Topical Area: 
Biomedicine
Research Interests: 

Design, characterization and validation of nanotechnologies for targeted drug delivery

Nanoliposmes, nanodendrimers, and nanocolloids as effective drug delivery vehicles for pharmacological and molecular agents

Nontoxic nanoscale systemic delivery systems for hydrophobic pro-apoptotic lipids and siRNAs that target mutated tumorigenic proteins

One-Page Research Brochure

Position 2: 
Co-Director of nanoSTAR
Department: